a33
mAbexperimentalImaging agent
A33, A 33 or A-33 may refer to :Douglas A-33, a 1941 American ground-attack fighter aircraft A33 Excelsior British heavy tank prototype HLA-A33, a human serotype Samsung Galaxy A33 5G, an Android smartphone — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 1998 (NCT00003360)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cell surface A33 antigenBINDING AGENT
GPA33 binding agent
- Myeloid cell surface antigen CD33INHIBITOR
CD33 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Imaging
- 125-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaA33 ↗
- ChEMBLCHEMBL2109642 ↗
Also known as
- a33
- a33
- a33
- a33 131i
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00199862 | N/A | Feb 1, 2004 | Cornell University, Ludwig Institute for Cancer Research |
| NCT00003543 | Phase 1 | Jun 1, 1998 | Cornell University, National Cancer Institute (NCI) |
| NCT00003360 | Phase 1 | Apr 1, 1998 | Cornell University, National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 3 | 3 | 2 | 1998 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 1998 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1